Regeneron Pharmaceuticals
Biotechnology company
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, it branched out into the study of both cytokine and tyrosine kinase receptors.
Visit website: https://www.regeneron.com/
Details last updated 05-May-2020
People at Regeneron Pharmaceuticals
Regeneron Pharmaceuticals News
Genetic profiling conducted by the mexico city prospective study highlights the value of genetic studies in diverse populations
Oxford Population Health - 11-Oct-2023
Study reveals new insights into obesity, diabetes, and genetic diversity
Read more...Unity Biotechnology's diabetic macular edema senolytic treatment shows promise at 48-week endpoint
FierceBiotech - 24-Apr-2023
Corporate shift towards ophthalmology puts senolytics head-to-head against existing treatments
Read more...New CRISPR gene-editing drug for a rare protein-misfolding disorder
pharmaphorum - 28-Jun-2021
Phase 1 trial reports, single dose of the drug cuts protein levels by 87% in ATTR amyloidosis
Read more...Adicet merges with resTorbio for CAR T-cell therapy pipeline funding
FierceBiotech - 30-Apr-2020
The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year
Read more...How DNA sequencing is transforming the hunt for new drugs
Reuters - 13-May-2015
Pharmaceuticals companies analysings hundreds of thousands of DNA samples to identify new gene ta...
Read more...
